BCL2L1 and gastric cancer: This study identifies a CDK1-SOX9-BCL-xL signaling axis as an important mediator of chemoresistance in gastric cancer.<h4>Methods</h4>Bioinformatics and computational approaches were used for analysis of human and mouse public and local data sets.